Novo Nordisk’s Wegovy has been approved for sale in China, Stephanie Stacey and Ian Johnston of The Financial Times reports. It is not yet known when the product will launch, the pricing of the drug, or the volume of the product that will be supplied to the region.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
Questions or Comments about the article? Write to editor@tipranks.com